Zydus receives WHO acceptability for ZyVac TCV, eligible for UN agency purchases
ZyVac TCV, developed by Zydus Lifesciences, gains prequalification from WHO for global typhoid immunisation programmes
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.